Charlotte Slabbinck SRL
Charlotte Slabbinck reported total assets of 72,938 € at the end of the 2026 financial year (annual accounts filed with the NBB on 20 Oct 2026).
The score of Charlotte Slabbinck shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Charlotte Slabbinck's annual accounts
Filed annual accounts
- Year ended 30 Jun 2026filed on 20 Oct 2026
- Year ended 30 Jun 2025filed on 28 Oct 2025
Charlotte Slabbinck's financial analysis
- Solvency36.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Charlotte Slabbinck
Charlotte Slabbinck's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1017.048.364
- VAT number
- BE1017048364
- Peppol
- Registered · 0208:1017048364 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 2024
- Registered office
- 8460 Oudenburg
- Latest accounts
- 2026 · filed on 20 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Charlotte Slabbinck (SRL) has been based in Oudenburg since 2024, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 18,306 € and equity of 26,384 €; its revenue is not published. Its solvency stands at 36.2%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Charlotte Slabbinck
Companies in the same business, of comparable size and area, outside its group.
- Apr. ZEYREK Retail sale of pharmaceutical products Leuven · balance sheet 72,982 €
- Apotheker Van De Weghe Karen Retail sale of pharmaceutical products Sint-Martens-Latem · balance sheet 73,167 €
- LouksPharma Retail sale of pharmaceutical products Fernelmont · balance sheet 72,654 €
- Carva Care Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 72,190 €
- Arkophar Retail sale of pharmaceutical products Zutendaal · balance sheet 73,718 €
- Sagenex Retail sale of pharmaceutical products Namur · balance sheet 73,820 €
- Arucarea Retail sale of pharmaceutical products Oud-Turnhout · balance sheet 73,983 €
- NED Pharma Retail sale of pharmaceutical products Mons · balance sheet 74,278 €
Frequently asked questions about Charlotte Slabbinck
What is the revenue of Charlotte Slabbinck?
Charlotte Slabbinck files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Charlotte Slabbinck?
In Belgium, the VAT number is the company number prefixed with BE: BE1017048364 for Charlotte Slabbinck, if the company is VAT-registered. Its company number (CBE) is 1017.048.364.
Where is the registered office of Charlotte Slabbinck?
According to the CBE register, the registered office of Charlotte Slabbinck is in 8460 Oudenburg.
What is the equity of Charlotte Slabbinck?
At the close of the 2026 financial year, the equity of Charlotte Slabbinck amounts to 26,384 €, a solvency of 36.2% of total assets.
Who manages Charlotte Slabbinck?
The register lists 1 active mandates at Charlotte Slabbinck. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Charlotte Slabbinck
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →